Cipla Limited has disclosed to stock exchanges that the Goods & Service Tax Department, Maharashtra initiated inspection proceedings at certain company facilities and offices located in Maharashtra on February 5, 2026. The pharmaceutical company made this disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, emphasizing that no financial impact is expected from these proceedings.

Inspection Details

The inspection was initiated by the Deputy Commissioner of State Tax, Maharashtra at 1230 hours on February 5, 2026. The proceedings fall under Section 67 of the Maharashtra Goods & Service Tax Act, 2017, which covers inspection under sub-section (1) and search under sub-section (2).

Scope of Investigation

The inspection and search proceedings relate to multiple areas of GST compliance. The company has disclosed that the investigation covers payment of tax, claim of input tax credit and refund matters, among other areas. These represent key components of GST compliance that are typically scrutinized during departmental inspections.

Company Response and Impact

Cipla has stated that it is extending full cooperation and assistance to the authorities during the ongoing proceedings. The company has emphasized its commitment to compliance and transparency throughout the process, while confirming that no financial impact is anticipated from these inspection activities.

Regulatory Compliance

The disclosure was made pursuant to SEBI Listing Regulations and follows the format specified in SEBI Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The company secretary Rajendra Chopra signed the disclosure document, ensuring compliance with regulatory requirements for transparency in material events that could impact stakeholder interests.

Cipla Limited has allotted 8,879 equity shares under its employee stock option schemes, marking another step in its employee compensation programs. The pharmaceutical company informed stock exchanges about this corporate action on January 28, 2026, in compliance with regulatory requirements.

Share Allotment Details

The Operations and Administrative Committee of Cipla approved the allotment of 8,879 fully paid-up equity shares on January 28, 2026. These shares were issued pursuant to the exercise of employee stock options and stock appreciation rights under two specific schemes.

Employee Stock Option Schemes

The share allotment was executed under two employee compensation schemes:

• Employee Stock Option Scheme 2013-A: A long-standing equity compensation program for employees
• Cipla Employee Stock Appreciation Rights Scheme 2021: A more recent scheme offering stock appreciation rights to eligible employees

These schemes are designed to provide equity-based compensation to employees, aligning their interests with shareholders and supporting employee retention.

Impact on Share Capital

Following the allotment, Cipla's capital structure has been updated to reflect the additional shares issued.

Regulatory Compliance

Cipla has notified multiple stock exchanges about this allotment in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company informed:

• BSE Limited (Scrip Code: 500087)
• National Stock Exchange of India Limited (Scrip Code: CIPLA)
• Societe de la Bourse de Luxembourg

The company also copied Central Depository Services (India) Limited and National Securities Depository Limited on the communication, ensuring all relevant depositories are informed of the capital structure changes.

This allotment represents a routine corporate action as part of Cipla's ongoing employee compensation programs, reflecting the company's commitment to equity-based employee incentives.